Comparative proteomic analysis of plasma proteins in patients with age-related macular degeneration

International Journal of Ophthalmology

Volumn 7, Issue 2, 2014, Pages 256-263

  Xu, Xin Rong ^a   Zhong, Lu ^a   Huang, Bing Lin ^a   Wei, Yuan Hua ^a   Zhou, Xin ^a   Wang, Ling ^b   Wang, Fu Qiang ^b  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Age related macular degeneration; Clinical patients; Comparative proteomics; Plasma proteins; Two dimensional electrophoresis

Indexed keywords

EID: 84899816084     PISSN: 22223959     EISSN: 22274898     Source Type: Journal    
DOI: 10.3980/j.issn.2222-3959.2014.02.12     Document Type: Article

References (34)

1. Rudnicka AR, JarrarZ, Worm aid R, Cook DG, Fletcher A, Owen CG. Age and gender variations in age-related macul a r degeneration prevalencein populations of European ancestry: a meta-Analysis. Ophthalmogy. 2012;ll9(3):57l-58o. [PubMed]
2. Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet. 2012;379(9827):l728-1738. [PubMed]
3. Jarrett SG, Boulton ME. Consequences of oxidative stress in age-related macular degeneration. Mol Aspects Med. 2012;33(4):399-417. [PMCfreearticle] [PubMed]
4. Liang FQ, Godley BF. Oxidativestress-inducedmitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp Eye Res. 2003576(4) 1397-403. [PubMed]
5. Howes KA, Liu Y, Dunaief JL, Mil am A, Frederick JM, Marks A, Baehr W. Receptor for advanced gly cation end products and age-related macular degeneration. Invest Ophthalmol Vis Sci. 2004;45(10):37l3-3720. [PubMed]
6. Iannaccone A, Neeli I, Krishnamurthy P, Lenchik NI, Wan H, Gerling IC, Desider10DM, Radic MZ. Autoimmune bmarkers in age-related macular degeneration: a possible role player in disease devement and progressn. Adv Exp MedBil. 2012;723:ll-l6. [PubMed]
7. Barelli S, Crettaz D, Thadikkaran L, Rubin O, Tissot JD. Plasma/serum proteomics: pre-Analytical issues. Expert Rev Proteomics. 2007;4(3):363-37O. [PubMed]
8. NordgaardCL, Berg KM, Kapphahn RJ, Reilly C, FengX, Olsen TW, Ferrington DA. Proteomics of the retinal pigment epithelium reveals altered protein expressn at progressive stages of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2006;47(3):8l5-822. [PubMed]
9. NordgaardCL, Karunadharma PP, FengX, Olsen TW, Ferrington DA. Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008549(7):2848-2855. [PubMed]
10. National fundus disease study group Clinical diagnostic criteria for age-related macular degeneration. RecAdv Ophthalmol. 1986;6(4):14-15.
11. Gupta N, Shankernarayan NP, Dharmalingam K. Serum proteome of leprosy patients undergoing erythema nodosum leprosum reaction: regulation of expressn of the isoforms of haptogl obi n. J Proteome Res. 200756(9) :3 669-3 679. [PubMed]
12. RabiludT. Silver staining of 2Delectrophoresis gels. Methods Mol Bil. 20125893:61-73. [PubMed]
13. Khandhadia S, Cipriani V, Yates JR, tery A J. Age-related macular degeneration and the complement system. Immunobgy. 2012;217(2):l27-l46. [PubMed]
14. Yuan X, Gu X, Crabb JS, YueX, Shadrach K, Hy fi el d JG, Crabb JW. Quantitative proteomics: comparison of the macular Bruch membrane/choroidcomplex from age-related macular degeneration and normal eyes. Mol Cell Proteomics. 2010;9(6):103l-1046. [PMCfreearticle] [PubMed]
15. Yan Q, Li Y, Hendrickson A, Sage EH. Regulation of retinal capillary cells by basic fibroblast growth factor, vascular endothelial growth factor, and hypoxia. In VitroCell Dev Bil Anim. 2001;37(l):45-49. [PubMed]
16. Kocak N, Alacacglu I, Kaynak S, Ozcan MA, Celik O, Yuksel F, Piskin O, Oner H, Saatci AO, Ergin M. Comparison of vitreous and plasma levels of vascular endothelial growth factor, interleukin-6 and hepatocyte growth factor in diabetic and non-diabetic retinal detachment cases. Ann Ophthalmol (Skokie) 2010542:10-14. [PubMed]
17. AutieroM, Luttun A,Tjwa M, Carmeliet P. Placental growth factor and its receptor, vascular endothelial growth factor receptor-l: novel targets for stimulation of ischemic tissue revascularization and inhibition of anggenicand inflammatory disorders. JThromb Haemost. 2003;l(7):l356-l37O. [PubMed]
18. Abe R, Yamagishi S, Fujita Y, Hoshina D, Sasaki M, Nakamura K, Matsui T, Shimizu T, Bucala R, Shimizu H. Topical application of anti-Anggenicpeptides based on pigment epithelium-derived factor can improve psoriasis. J Dermatol Sci. 2010;57(3):l83-l9l. [PubMed]
19. 19-Zhang H, ZhaoWJ, Kang LC, WangXH, BoXW. Characterization of a Moniezia expansa ubiquitin-conjugating enzyme E2 cDNA. Mol Bil Rep. 2010;37(3):1585- 1590. [PubMed]
20. Bukrinsky M. How toengageCofilin. Retrovirogy. 200855:85. [PMCfreearticle] [PubMed]
21. Gross JD, MatsuoH, Fletcher M, Sachs AB, Wagner G. Interactions of the eukary otic translation initiation factor eIF4E. Cold Spring Harb Symp Quant Bil. 2001566:397-402. [PubMed]
22. Strzalka W, Ziemienowicz A. Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication andcell cycle regulation. Ann Bot. 2011;l07(7):ll27-ll40. [PMCfree article] [PubMed]
23. Heron-Mil ha vet L, Khouya N, Fernandez A, Lamb NJ. Aktl a ndAkt2: differentiating the aktion. Histol Histopathol. 2011;26(5):65l-662. [PubMed]
24. Morrow G, Tanguay RM. Small heat shock protein expressn and functions during devement. Int J Bichem Cell Bil. 2012;44(10):l6l3-l62l. [PubMed]
25. Miravitlles M. Alpha-l-Antitrypsin and other proteinase inhibitors. Curr Opin Pharmacol. 2012;12(3):3O9-314. [PubMed]
26. Kalsheker N, Morley S, Morgan K. Gene regulation of the serine proteinase inhibitors alphal-Antitrypsin and alphal-Antichymotrypsin. Bichem SocTrans. 2002;3o(2):93-98. [PubMed]
27. Col man RW, Wu Y, Liu Y. Mechanisms by which cleaved kininogen inhibits endothelial cell differentiation and signalling. Thromb Haemost. 2010;104(5):875-88s. [PubMed]
28. Speeckaert M, Huang G, Delanghe JR, Taes YE. Bigical and clinical aspects of the vitamin D binding protein (Gc-gbulin) and its polymorphism. Clin Chim Acta. 2006;372(l-2):33-42. [PubMed]
29. Wolf G. Serum retinol-binding protein: a linkbetween obesity, insulin resistance, andtype 2 diabetes. Nutr Rev. 2007;65(5):25l-256. [PubMed]
30. Ifuku K, EndoT, Shikanai T, AroEM. Structure of the chroplast NADHdehydrogenase-1 ike complex: nomenclature for nuclear-encoded su bun its. Plant Cell Phys. 201155 2(93:1560-15 68. [PubMed]
31. Sniderman AD, Marcovina SM. Apolipoprotein Al and B. Clin Lab Med. 2006;26(4):733-750. [PubMed]
32. Gafian A, Corella D, Guillen M, Ordovas JM, Pocovi M. Frequencies of apolipoprotein A4 gene polymorphisms and association with serum lipid concentrations in two healthy Spanish populations. Hum Bil. 2004576(23:253-266. [PubMed]
33. Gordon SM, Davidson WS. Apolipoprotein A-I mimetics and high-density lipoprotein function. Curr Opin Endocrinol Diabetes Obes. 2012;l9(2):l09-ll4. [PubMed]
34. LucG, BardJM, Evans A, Arveiler D, Ruidavets JB, Amouyel P, Ducimetiere P. The relationship between apolipoprotein Al-containing lipoprotein fractions and environmental factors: the prospective epidemgical study of myocardial infarction (PRIME study) Atherosclerosis. 2000l52(2):399-405. [PubMed]